Share-Based Compensation	9 Months Ended
Sep. 30, 2022
Share-Based Compensation
Share-Based Compensation	11. Share-Based Compensation Performance-Contingent Awards The Company periodically grants performance-contingent share-based awards to employees. For the three and nine months ended September 30, 2022, the Company recognized $0.4 million and $0.6 million, respectively, of share-based compensation expense related to these types of awards. As of September 30, 2022, there were 305,000 shares of performance-contingent restricted share units (“RSUs”) outstanding that have a maximum remaining share-based compensation expense of $2.1 million with performance vesting dates through February 2027. For the three and nine months ended September 30, 2021, the Company recognized $0.1 million and $0.7 million, respectively, of share-based compensation expense related to performance-contingent share-based awards. Share-Based Compensation Modification Due to Corporate Restructuring As a result of the Company’s corporate restructuring announcement in September 2021 (see Note 13), the Board of Directors’ Compensation Committee approved the acceleration of certain equity awards for employees affected by the restructuring. The Company accounted for this acceleration as a Type III modification (improbable to probable) which resulted in a fair value of $2.5 million, as of the modification date, that was recorded in “Restructuring and related expenses” within the condensed consolidated statements of operations. The total cumulative compensation cost previously recognized for these awards of $0.8 million within “Research and development” and “Selling, general and administrative” expenses through the modification date, was reversed. The acceleration resulted in net incremental share-based compensation expenses of $1.7 million for nine months ended September 30, 2022 and impacted approximately 45 terminated employees who met the conditions of the acceleration and departed the Company in the first half of 2022. There were no net incremental share-based compensation expenses related to the acceleration for the three months ended September 30, 2022.

Share-Based Compensation

9 Months Ended

Sep. 30, 2022

11. Share-Based Compensation

Performance-Contingent Awards

The Company periodically grants performance-contingent share-based awards to employees. For the three and nine months ended September 30, 2022, the Company recognized $0.4 million and $0.6 million, respectively, of share-based compensation expense related to these types of awards. As of September 30, 2022, there were 305,000 shares of performance-contingent restricted share units (“RSUs”) outstanding that have a maximum remaining share-based compensation expense of $2.1 million with performance vesting dates through February 2027. For the three and nine months ended September 30, 2021, the Company recognized $0.1 million and $0.7 million, respectively, of share-based compensation expense related to performance-contingent share-based awards.

Share-Based Compensation Modification Due to Corporate Restructuring

As a result of the Company’s corporate restructuring announcement in September 2021 (see Note 13), the Board of Directors’ Compensation Committee approved the acceleration of certain equity awards for employees affected by the restructuring. The Company accounted for this acceleration as a Type III modification (improbable to probable) which resulted in a fair value of $2.5 million, as of the modification date, that was recorded in “Restructuring and related expenses” within the condensed consolidated statements of operations. The total cumulative compensation cost previously recognized for these awards of $0.8 million within “Research and development” and “Selling, general and administrative” expenses through the modification date, was reversed. The acceleration resulted in net incremental share-based compensation expenses of $1.7 million for nine months ended September 30, 2022 and impacted approximately 45 terminated employees who met the conditions of the acceleration and departed the Company in the first half of 2022. There were no net incremental share-based compensation expenses related to the acceleration for the three months ended September 30, 2022.